Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Share Price    (DIVI)

Here is the latest stock price and chart of Divis Laboratories. For more details, see the Divis Laboratories company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.

EV Stocks: Make a Fortune from Automobile Sector's Colossal Disruption

REFRESH
Live BSE Quotes Oct 14, 2021 (Close)
Price (Rs)5,373.80 Open (Rs) 5,246.00 High (Rs) 5,387.80 Low (Rs) 5,230.05
% Change2.43 Volume 16,497 Value (Rs) 88,184,302 52-Week H/L 5,387.80 / 3,015.00
Live NSE Quotes Oct 14, 2021 (Close)
Price (Rs)5,372.15 Open (Rs) 5,248.90 High (Rs) 5,389.00 Low (Rs) 5,226.20
% Change2.35 Volume 549,795 Value (Rs) 2,936,864,219 52-Week H/L 5,389.00 / 3,015.00
Change
1 Day
2.43%
1 Month
5.53%
3 Months
16.24%
1 Year
71.76%
5 Years (CAGR)*
34.19%
10 Years (CAGR)*
30.79%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 77.20 P/E Ratio (x) 69.61 Market Cap (Rs m) 1,426,575.16 P/BV (x) 15.35 Dividend Yield (%) 0.37
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

DIVIS LABORATORIES Share Price Today:

DIVIS LABORATORIES last traded price was up 2.4% to Rs 5,373.8 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was up 2.4% to Rs 5,372.2. The total volume of shares traded was 0.6 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.3%. And the benchmark S&P BSE SENSEX was at 61,306.0 (up 0.9%).

Over the last 30 days, the DIVIS LABORATORIES share price is up 5.7%. And over the last one year, DIVIS LABORATORIES share price is up 70.9%.

The current market capitalisation of DIVIS LABORATORIES stands at Rs 1,426,575.16 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of September 2021, company promoters held 51.95% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views On News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - TEVA PHARMA COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS